Date
- Wednesday, 12 September 2018, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The Committee for Advanced Therapies is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines, including medicines classified as gene-therapy, somatic-cell-therapy or tissue-engineered products. Abbreviated as CAT. For more information, see Committee for Advanced Therapies (CAT). (CAT) is the committee that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicines.